Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Mirati Therapeutics (NQ: MRTX)
117.38 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 5:50 PM EDT, Jul 7, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 117.38
Bid (Size) 117.13 (4)
Ask (Size) 117.40 (8)
Prev. Close 117.38
Today's Range 117.38 - 117.38
52wk Range 66.01 - 132.59
Shares Outstanding 32,214,631
Dividend Yield N/A
Performance
YTD
+1.01%
+1.01%
1 Month
+12.45%
+12.45%
3 Month
+52.76%
+52.76%
6 Month
+14.22%
+14.22%
1 Year
+10.87%
+10.87%
Top News
More News
Mirati Therapeutics to Present at 41st Annual Goldman Sachs Global Healthcare Conference
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will participate in the upcoming 41st Annual Goldman Sachs Global Healthcare Conference on Thursday, June 11, 2020.... Read More
from PR Newswire
Mirati Therapeutics Appoints Joseph A. Leveque, M.D. As Chief Medical Officer
- Dr. Joseph Leveque, who has an extensive and successful track record of advancing oncology clinical development programs into and through commercialization, has been named Chief Medical Officer Read More
from PR Newswire
More News
Read More
Mirati Therapeutics To Present Preclinical Data From Investigational Pipeline Of Novel Therapeutics At 2020 American Association For Cancer Research Virtual Annual Meeting II
from PR Newswire
Mirati Therapeutics Reports First Quarter 2020 Financial Results And Recent Corporate Updates
from PR Newswire
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Mirati Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
from PR Newswire
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Mirati Therapeutics, Inc. for Potential Breach of Fiduciary Duty Claims
from GlobeNewswire News Releases
MRTX Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Mirati Therapeutics, Inc. and Encourages Investors to Contact the Firm
from PR Newswire
Interesting MRTX Put And Call Options For October 16th
category Stocks
from Market News Video
2 Biotech Stocks That Could Soar in 2020
category IGMS , HRTX , ABBV , and 7 more.
from Motley Fool
Mirati Therapeutics Hits 80-Plus Relative Strength Rating Benchmark
from Investor's Business Daily
Stocks Flashing Renewed Technical Strength: Mirati Therapeutics
from Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.